StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3032% below fair value
$58.34−1.22 (-2.05%)

Close on Nov 19, 2026Market cap $119.25BP/E 12.9Yield 4.27%

Bristol Myers Squibb Specified Items in Cost of Products Sold by Quarter

Specified Items in Cost of Products Sold ($M) ($M)

Bristol Myers Squibb Specified Items in Cost of Products Sold: $13M in Q3 2026, down 89.3% from a year earlier.

Latest, Q3 2026
13
Period ended Sep 30, 2026
Change on a year earlier
-89.3%
122 in Q3 2025
History
38 quarters
Since Q4 2016
Sources
34
Documents cited below

Where the Q3 2026 figure comes from

“|| Cost of products sold | 13 | 122 | 41 | 152”

Source: Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗

Reported in Form 8-K Specified Items Schedule.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecified Items in Cost of Products Sold ($M) ($M)Year on yearSource
Q3 2026Sep 30, 202613-89.3%Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗
Q2 2026Jun 30, 202615-6.2%Form 8-K (a2026q2ex991-filing.htm, filed 2026-07-30) ↗
Q1 2026Mar 31, 202613-7.1%Form 8-K (a2026q1ex991.htm, filed 2026-04-30) ↗
Q4 2025Dec 31, 2025589-63.2%Form 8-K (a2025q4ex991.htm, filed 2026-02-05) ↗
Q3 2025Sep 30, 2025122+20.8%Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗
Q2 2025Jun 30, 202516-94.6%Form 8-K (a2026q2ex991-filing.htm, filed 2026-07-30) ↗
Q1 2025Mar 31, 202514-36.4%Form 8-K (a2026q1ex991.htm, filed 2026-04-30) ↗
Q4 2024Dec 31, 20241,600+4,110.5%Form 8-K (a2025q4ex991.htm, filed 2026-02-05) ↗
Q3 2024Sep 30, 2024101+531.3%Form 8-K (a2025q3ex991.htm, filed 2025-10-30) ↗
Q2 2024Jun 30, 2024296+341.8%Form 8-K (a2025q2ex991-filing.htm, filed 2025-07-31) ↗
Q1 2024Mar 31, 202422-59.3%Form 8-K (a2025q1ex991-filing.htm, filed 2025-04-24) ↗
Q4 2023Dec 31, 202338-47.9%Form 8-K (a2024ex991-filing.htm, filed 2025-02-06) ↗
Q3 2023Sep 30, 202316-81.4%Form 8-K (q32024ex991-filing.htm, filed 2024-10-31) ↗
Q2 2023Jun 30, 202367-53.8%Form 8-K (q22024ex991-filing.htm, filed 2024-07-26) ↗
Q1 2023Mar 31, 202354+3.8%Form 8-K (q12024ex991-filing.htm, filed 2024-04-25) ↗
Q4 2022Dec 31, 202273–Form 8-K (q42023ex991-filing.htm, filed 2024-02-02) ↗

Breakdown

What makes up specified Items in Cost of Products Sold

Cite this data

StockData. (2026). Bristol Myers Squibb Specified Items in Cost of Products Sold ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Bristol Myers Squibb SEC filings and investor materials. https://stockdatahq.com/stocks/bmy/kpis/spec-cogs-tot

See every metric in the Bristol Myers Squibb KPI table. Data updated Nov 3, 2026.

See a number that looks wrong?